View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088
  • 2 Szegedi Tudományegyetem, Általános Orvostudományi Kar I. Belgyógyászati Klinika Szeged
  • 3 Debreceni Tudományegyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika, Belgyógyászati Intézet, Gasztroenterológiai Tanszék Debrecen
  • 4 Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi Oktató Kórház Miskolc
  • 5 Bács-Kiskun Megyei Önkormányzat Kórháza Kecskemét
  • 6 Szegedi Tudományegyetem, Általános Orvostudományi Kar, Természettudományi és Informatikai Kar Orvosi Fizikai és Orvosi Informatikai Intézet Szeged
Open access

A gyulladásos bélbetegségben érintett betegek növekvő száma és az új terápiás lehetőségek miatt jelentősen megnőtt az igény a standardizált adatok vizsgálatára. Magyarországon évek óta működik olyan betegregiszter, amelyben lehetőség van a gyulladásos bélbetegek adatainak prospektív gyűjtésére. Cél: Jelen dolgozatban a szerzők colitis ulcerosában szenvedő betegek jellemző adatait ismertetik. Módszerek: A regiszter a Microsoft Access adatbázis-kezelő programján működik. Az adatokat központi szerveren tárolják. Eredmények: Hazánkban is nő a gyulladásos bélbetegség gyakorisága – egyelőre az alacsony előfordulási gyakoriságú országok közé tartozunk. Míg az immunszupprimáló kezelésben nem részesülő betegek aktivitásának megbecslésében szerepe lehet a laboratóriumi paramétereknek és a C-reaktív fehérjének, addig az immunszupprimáló kezelés az aktivitás becslését rontja. Következtetések: 1. Hasznos lenne, ha az ország összes jelentős, gyulladásos bélbeteget gondozó munkahelye csatlakozna az adatközösséghez, és a folyamatos regisztrálással országos képet kaphatnánk. 2. A laboratóriumi paraméterek értékelésekor figyelembe kell venni a beteg aktuális kezelését. Orv. Hetil., 2012, 153, 702–712.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Cosnes, J., Gower-Rousseau, C., Seksik, P., et al.: Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology, 2011, 140, 1785–1794.

    Seksik P. , 'Epidemiology and natural history of inflammatory bowel diseases ' (2011 ) 140 Gastroenterology : 1785 -1794.

    • Search Google Scholar
  • Lakatos, L., Kiss, L. S., David, G., et al.: Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006. Inflamm. Bowel Dis., 2011, 17, 2558–2565.

    David G. , 'Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006 ' (2011 ) 17 Inflamm. Bowel Dis. : 2558 -2565.

    • Search Google Scholar
  • Sandborn, W. J.: Why innovation in inflammatory bowel disease drug development will impact your practice. Clin. Gastroenterol. Hepatol., 2011, 9, 211–213.

    Sandborn W. J. , 'Why innovation in inflammatory bowel disease drug development will impact your practice ' (2011 ) 9 Clin. Gastroenterol. Hepatol. : 211 -213.

    • Search Google Scholar
  • Cohen, R. D., Thomas, T.: Economics of the use of biologics in the treatment of inflammatory bowel disease. Gastroenterol. Clin. North Am., 2006, 35, 867–882.

    Thomas T. , 'Economics of the use of biologics in the treatment of inflammatory bowel disease ' (2006 ) 35 Gastroenterol. Clin. North Am. : 867 -882.

    • Search Google Scholar
  • Prenzel, F., Uhlig, H. H.: Frequency of indeterminate colitis in children and adults with IBD – a metaanalysis. J. Crohns Colitis, 2009, 3, 277–281.

    Uhlig H. H. , 'Frequency of indeterminate colitis in children and adults with IBD – a metaanalysis ' (2009 ) 3 J. Crohns Colitis : 277 -281.

    • Search Google Scholar
  • Meucci, G., Bortoli, A., Riccioli, F. A., et al.: Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali). Eur. J. Gastroenterol. Hepatol., 1999, 11, 909–913.

    Riccioli F. A. , 'Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali) ' (1999 ) 11 Eur. J. Gastroenterol. Hepatol. : 909 -913.

    • Search Google Scholar
  • Auvin, S., Molinie, F., Gower-Rousseau, C., et al.: Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988–1999). J. Pediatr. Gastroenterol. Nutr., 2005, 41, 49–55.

    Gower-Rousseau C. , 'Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988–1999) ' (2005 ) 41 J. Pediatr. Gastroenterol. Nutr. : 49 -55.

    • Search Google Scholar
  • Langholz, E., Munkholm, P., Krasilnikoff, P. A., et al.: Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand. Gastroenterol., 1997, 32, 139–147.

    Krasilnikoff P. A. , 'Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort ' (1997 ) 32 Scand. Gastroenterol. : 139 -147.

    • Search Google Scholar
  • Vavricka, S. R., Spigaglia, S. M., Rogler, G., et al.: Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm. Bowel Dis., 2012, 18, 496–505.

    Rogler G. , 'Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease ' (2012 ) 18 Inflamm. Bowel Dis. : 496 -505.

    • Search Google Scholar
  • Henriksen, M., Jahnsen, J., Lygren, I., et al.: Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand. J. Gastroenterol., 2006, 41, 1037–1043.

    Lygren I. , 'Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study) ' (2006 ) 41 Scand. J. Gastroenterol. : 1037 -1043.

    • Search Google Scholar
  • Boniol, M., Autier, P.: Prevalence of main cancer lifestyle risk factors in Europe in 2000. Eur. J. Cancer, 2010, 46, 2534–2544.

    Autier P. , 'Prevalence of main cancer lifestyle risk factors in Europe in 2000 ' (2010 ) 46 Eur. J. Cancer : 2534 -2544.

    • Search Google Scholar
  • Matsushita, M., Takakuwa, H., Matsubayashi, Y., et al.: Appendix is a priming site in the development of ulcerative colitis. World J. Gastroenterol., 2005, 11, 4869–4874.

    Matsubayashi Y. , 'Appendix is a priming site in the development of ulcerative colitis ' (2005 ) 11 World J. Gastroenterol. : 4869 -4874.

    • Search Google Scholar
  • Radford-Smith, G. L., Edwards, J. E., Purdie, D. M., et al.: Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease. Gut, 2002, 51, 808–813.

    Purdie D. M. , 'Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease ' (2002 ) 51 Gut : 808 -813.

    • Search Google Scholar
  • Selby, W. S., Griffin, S., Abraham, N., et al.: Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am. J. Gastroenterol., 2002, 97, 2834–2838.

    Abraham N. , 'Appendectomy protects against the development of ulcerative colitis but does not affect its course ' (2002 ) 97 Am. J. Gastroenterol. : 2834 -2838.

    • Search Google Scholar
  • Bernstein, C. N., Wajda, A., Svenson, L. W., et al.: The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am. J. Gastroenterol., 2006, 101, 1559–1568.

    Svenson L. W. , 'The epidemiology of inflammatory bowel disease in Canada: a population-based study ' (2006 ) 101 Am. J. Gastroenterol. : 1559 -1568.

    • Search Google Scholar
  • Gearry, R. B., Richardson, A., Frampton, C. M., et al.: High incidence of Crohn’s disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm. Bowel Dis., 2006, 12, 936–943.

    Frampton C. M. , 'High incidence of Crohn’s disease in Canterbury, New Zealand: results of an epidemiologic study ' (2006 ) 12 Inflamm. Bowel Dis. : 936 -943.

    • Search Google Scholar
  • Somerville, K. W., Logan, R. F., Edmond, M., et al.: Smoking and Crohn’s disease. Br. Med. J. (Clin. Res. Ed.), 1984, 289, 954–956.

    Edmond M. , 'Smoking and Crohn’s disease ' (1984 ) 289 Br. Med. J. (Clin. Res. Ed.) : 954 -956.

    • Search Google Scholar
  • Persson, P. G., Ahlbom, A., Hellers, G.: Inflammatory bowel disease and tobacco smoke – a case-control study. Gut, 1990, 31, 1377–1381.

    Hellers G. , 'Inflammatory bowel disease and tobacco smoke – a case-control study ' (1990 ) 31 Gut : 1377 -1381.

    • Search Google Scholar
  • El-Tawil, A. M.: Smoking and inflammatory bowel diseases: what in smoking alters the course? Int. J. Colorectal. Dis., 2010, 25, 671–680.

    El-Tawil A. M. , 'Smoking and inflammatory bowel diseases: what in smoking alters the course? ' (2010 ) 25 Int. J. Colorectal. Dis. : 671 -680.

    • Search Google Scholar
  • Lakatos, P. L., Szamosi, T., Lakatos, L.: Smoking in inflammatory bowel diseases: good, bad or ugly? World J. Gastroenterol., 2007, 13, 6134–6139.

    Lakatos L. , 'Smoking in inflammatory bowel diseases: good, bad or ugly? ' (2007 ) 13 World J. Gastroenterol. : 6134 -6139.

    • Search Google Scholar
  • Birrenbach, T., Bocker, U.: Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm. Bowel Dis., 2004, 10, 848–859.

    Bocker U. , 'Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications ' (2004 ) 10 Inflamm. Bowel Dis. : 848 -859.

    • Search Google Scholar
  • Calkins, B. M.: A meta-analysis of the role of smoking in inflammatory bowel disease. Dig. Dis. Sci., 1989, 34, 1841–1854.

    Calkins B. M. , 'A meta-analysis of the role of smoking in inflammatory bowel disease ' (1989 ) 34 Dig. Dis. Sci. : 1841 -1854.

    • Search Google Scholar
  • Solberg, I. C., Vatn, M. H., Hoie, O., et al.: Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin. Gastroenterol. Hepatol., 2007, 5, 1430–1438.

    Hoie O. , 'Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study ' (2007 ) 5 Clin. Gastroenterol. Hepatol. : 1430 -1438.

    • Search Google Scholar
  • Munkholm, P., Langholz, E., Davidsen, M., et al.: Disease activity courses in a regional cohort of Crohn’s disease patients. Scand. J. Gastroenterol., 1995, 30, 699–706.

    Davidsen M. , 'Disease activity courses in a regional cohort of Crohn’s disease patients ' (1995 ) 30 Scand. J. Gastroenterol. : 699 -706.

    • Search Google Scholar
  • Truelove, S. C., Witts, L. J.: Cortisone in ulcerative colitis; final report on a therapeutic trial. Br. Med. J., 1955, 2, 1041–1048.

    Witts L. J. , 'Cortisone in ulcerative colitis; final report on a therapeutic trial ' (1955 ) 2 Br. Med. J. : 1041 -1048.

    • Search Google Scholar
  • Van Assche, G., Vermeire, S., Rutgeerts, P.: Treatment of severe steroid refractory ulcerative colitis. World J. Gastroenterol., 2008, 14, 5508–5511.

    Rutgeerts P. , 'Treatment of severe steroid refractory ulcerative colitis ' (2008 ) 14 World J. Gastroenterol. : 5508 -5511.

    • Search Google Scholar